$4.22 1%
SANA Stock Price vs. AI Score
Data gathered: July 15

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Sana Biotechnology (SANA)

Analysis generated August 13, 2024. Powered by Chat GPT.

Sana Biotechnology is a biotechnology company specializing in creating and delivering engineered cells as a medication for patients. The company is at the cutting edge of the biotechnology industry, focusing on developing platforms intending to repair and control genes in cells and establish specific cell types to combat different diseases. The company’s ambitious goals are matched by its innovative approaches and significant investments in research and development.

Read full AI stock Analysis

Stock Alerts - Sana Biotechnology (SANA)

company logo Sana Biotechnology | July 10
AI Score is up by 33.5% in the last couple of days.
company logo Sana Biotechnology | July 9
Price is up by 7.3% in the last 24h.
company logo Sana Biotechnology | July 9
Reddit mentions are up by 1913% in the last 24h.
company logo Sana Biotechnology | July 8
Price is up by 8.7% in the last 24h.

Download our app to get future alerts delivered in real-time.

About Sana Biotechnology

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines.


Sana Biotechnology
Price $4.22
Target Price Sign up
Volume 5,830,000
Market Cap $943M
Year Range $1.34 - $4.3
Dividend Yield 0%
Analyst Rating 57% buy
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '25000-49M-47M-0.200
Q4 '24000-49M-43M-0.230
Q3 '24000-60M-57M-0.250
Q2 '2403.9M-3.9M-50M-46M-0.320
Q1 '2403.7M-3.7M-107M-104M-0.320

Insider Transactions View All

FMR LLC filed to sell 4,541,511 shares at $7.3.
January 10 '25
FMR LLC filed to sell 4,707,423 shares at $6.5.
January 10 '25
FMR LLC filed to sell 4,732,423 shares at $6.1.
January 10 '25
FMR LLC filed to sell 4,542,511 shares at $6.7.
January 10 '25
Mulligan Richard filed to sell 2,698,121 shares at $3.9.
September 26 '24

What is the Market Cap of Sana Biotechnology?

The Market Cap of Sana Biotechnology is $943M.

What is the current stock price of Sana Biotechnology?

Currently, the price of one share of Sana Biotechnology stock is $4.22.

How can I analyze the SANA stock price chart for investment decisions?

The SANA stock price chart above provides a comprehensive visual representation of Sana Biotechnology's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Sana Biotechnology shares. Our platform offers an up-to-date SANA stock price chart, along with technical data analysis and alternative data insights.

Does SANA offer dividends to its shareholders?

As of our latest update, Sana Biotechnology (SANA) does not offer dividends to its shareholders. Investors interested in Sana Biotechnology should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Sana Biotechnology?

Some of the similar stocks of Sana Biotechnology are Inovio Pharmaceuticals, Anavex Life Sciences, BridgeBio Pharma, Crispr Therapeutics, and Editas Medicine.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.